---
figid: PMC8709313__pharmaceutics-13-02201-g002
figtitle: TKI Era in Chronic Leukemias
organisms:
- NA
pmcid: PMC8709313
filename: pharmaceutics-13-02201-g002.jpg
figlink: /pmc/articles/PMC8709313/figure/pharmaceutics-13-02201-f002/
number: F2
caption: B-cell receptor signaling pathway.
papertitle: The TKI Era in Chronic Leukemias.
reftext: Danilo De Novellis, et al. Pharmaceutics. 2021 Dec;13(12):2201.
year: '2021'
doi: 10.3390/pharmaceutics13122201
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: chronic myeloid leukemia (CML) | chronic lymphocytic leukemia (CLL) | BCR-ABL1-inhibitors
  | BTK-inhibitors | PI3K-inhibitors | targeted therapy | treatment discontinuation
automl_pathway: 0.9626166
figid_alias: PMC8709313__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8709313__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8709313__pharmaceutics-13-02201-g002.html
  '@type': Dataset
  description: B-cell receptor signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD79B
  - CD79A
  - LYN
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - SYK
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - BLNK
  - BTK
  - NFKB1
  - EPHB2
  - MAPK1
  - MAPK3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CD19
  - AKT1
  - AKT2
  - AKT3
  - MTOR
---
